Anti-4-1BB-based immunotherapy for autoimmune diabetes: Lessons from a transgenic non-obese diabetic (NOD) model

Journal of Autoimmunity

Volumn 21, Issue 3, 2003, Pages 247-254

  Sytwu, Huey Kang ^a   Lin, Wen Der ^a   Roffler, Steve R ^b   Hung, Jung Tung ^a   Sung, Hsiang Sheng ^a   Wang, Chi Hsien ^a   Cheng, Tian Lu ^b   Tsou, Shey Cherng ^b   Hsi, Sheng Chuan ^c   Shen, Kuo Liang ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c TAO YUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

4 1BB; Autoimmune diabetes; Human insulin promoter (pIns); Non obese diabetic mice; Single chain anti 4 1BB Fv (anti 4 1BB scFv); Transgenic mice

Indexed keywords

FAS ANTIBODY; GLUTAMATE DECARBOXYLASE; RECOMBINANT TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; EMBRYO; ENCEPHALOMYELITIS; FEMALE; GENE OVEREXPRESSION; HEALTH STATUS; IMMUNE RESPONSE; IMMUNOTHERAPY; INCIDENCE; INSULITIS; LUPUS ERYTHEMATOSUS; LYMPHADENOPATHY; MALE; MORTALITY; MOUSE; NONHUMAN; OBESITY; ONSET AGE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 10744220063     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-8411(03)00112-4     Document Type: Conference Paper

References (28)

1. Bach J.F. Insulin-dependent diabetes mellitus is an autoimmune disease. Endocr Rev. 15:1994;516-542.
2. Singer S.M., Tisch R., Yang X.-D., Sytwu H.-K., Liblau R., McDevitt H.O. Prevention of diabetes in NOD mice by a mutated I-Ab transgene. Diabetes. 47:1998;1570-1577.
3. Chao C.C., Sytwu H.-K., Chen E.L., Toma J., McDevitt H.O. The role of MHC class II molecules in susceptibility to type I diabetes: Identification of peptide epitopes and characterization of the T cell repertoire. Proc Natl Acad Sci U S A. 96:1999;9299-9304.
4. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu Rev Immunol. 14:1996;233-258.
5. Melero I., Johnston J.V., Shufford W.W., Mittler R.S., Chen L. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. Cell Immunol. 190:1998;167-172.
6. DeBenedette M.A., Wen T., Bachmann M.F., Ohashi P.S., Barber B.H., Stocking K.L., et al. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J Immunol. 163:1999;4833-4841.
7. Tan J.T., Whitmire J.K., Ahmed R., Pearson T.C., Larsen C.P. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J Immunol. 163:1999;4859-4868.
8. Sun Y., Lin X., Chen H.M., Wu Q., Subudhi S.K., Chen L., et al. Administration of agonistic anti4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis. J Immunol. 168:2002;1457-1465.
9. Sun Y., Chen H.M., Subudhi S.K., Chen J., Koka R., Chen L., et al. Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease. Nat Med. 8:2002;1405-1413.
10. DeBenedette M.A., Shahinian A., Mak T.W., Watts T.H. Costimulation of CD28 T lymphocytes by 4-1BB ligand. J Immunol. 158:1997;551-559.
11. Shuford W.W., Klussman K., Tritchler D.D., Loo D.T., Chalupny J., Siadak A.W., et al. 4-1BB costimulatory signals preferentially induce CD8 T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med. 186:1997;47-55.
12. Melero I., Shuford W.W., Newby S.A., Aruffo A., Ledbetter J.A., Hellstrom K.E., et al. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med. 3:1997;682-685.
13. Takahashi C., Mittler R.S., Vella A.T. 4-1BB is a bona fide CD8 T cell survival signal. J Immunol. 162:1999;5037-5040.
14. DeBenedett M.A., Chu N.R., Pollok K.E., Hurtado J., Wade W.F., Kwon B.S., et al. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J Exp Med. 181:1995;985-992.
15. Gramaglia I., Cooper D., Miner K.T., Kwon B.S., Croft M. Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand. Eur J Immunol. 30:2000;392-402.
16. Liao K.W., Lo Y.C., Roffler S.R. Activation of lymphocytes by anti-CD3 single-chain antibody dimers expressed on the plasma membrane of tumor cells. Gene Ther. 7:2000;339-347.
17. Walunas T.L., Lenschow D.J., Bakker C.Y., Linsley P.S., Freeman G.J., Green J.M., et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1:1994;405-413.
18. Gilliland L.K., Norris N.A., Marquardt H., Tsu T.T., Hayden M.S., Neubauer M.G., et al. Rapid and reliable cloning of antibody variable regions and generation of recombinant single chain antibody fragments. Tissue Antigens. 47:1996;1-20.
19. Chou W.C., Liao K.W., Lo Y.C., Jiang S.Y., Yeh M.Y., Roffler S.R. Expression of chimeric monomer and dimer proteins on the plasma membrane of mammalian cells. Biotechnol Bioeng. 65:1999;160-169.
20. Don R.H., Cox P.T., Wainwright B.J., Baker K., Mattick J.S. 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 19:1991;4008.
21. Hotta M., Tashiro F., Ikegami H., Niwa H., Ogihara T., Yodoi J., et al. Pancreatic β cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J Exp Med. 188:1998;1445-1451.
22. Kurasawa K., Koike T., Matsumura R., Takabayashi K., Tomioka H., Ito I., et al. The immunosuppressant FK-506 prevents progression of diabetes in nonobese diabetic mice. Clin Immunol Immunopathol. 57:1990;274-279.
23. Sytwu H.K., Liblau R., McDevitt H.O. The roles of Fas/APO-1(CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity. 5:1996;17-30.
24. Winberg G., Grosmaire L.S., Klussman K., Hayden M.S., Fell H.P., Ledbetter J.A., et al. Surface expression of CD28 single chain Fv for costimulation by tumor cells. Immunol Rev. 153:1996;209-223.
25. Hayden M.S., Grosmaire L.S., Norris N.A., Gilliland L.K., Winberg G., Tritschler D., et al. Costimulation by CD28 sFv expressed on the tumor cell surface or as a soluble bispecific molecule targeted to the L6 carcinoma antigen. Tissue Antigens. 48:1996;242-254.
26. Melero I., Bach N., Hellstrom K.E., Aruffo A., Mittler R.S., Chen L. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway. Eur J Immunol. 28:1998;1116-1121.
27. Fox H.S. Androgen treatment prevents diabetes in nonobese diabetic mice. J Exp Med. 175:1992;1409-1412.
28. Fox H.S. Sex steroids and the immune system. Ciba Found Symp. 191:1995;203-211.